Literature DB >> 16316352

Early detection of progressive renal dysfunction in patients with coronary artery disease.

Giorgio Fuiano1, Domenico Mancuso, Ciro Indolfi, Annalisa Mongiardo, Massimo Sabbatini, Giuseppe Conte, Luca De Nicola, Roberto Minutolo, Giuseppe Mazza, Paola Cianfrone, Michele Andreucci.   

Abstract

BACKGROUND: An association between renal hemodynamic dysfunction and coronary artery disease (CAD) has been documented in chronic renal failure; however, no information is available in CAD patients with normal glomerular filtration rate (GFR). This study was aimed at evaluating early abnormalities and outcome of renal function in CAD patients.
METHODS: In 15 nondiabetic patients with normal renal function and no significant stenoses in renal arteries, and having undergone coronary arteriography, we studied systemic and renal hemodynamics before and after a vasodilating stimulus induced by aminoacid (AA) infusion. A control group (C) consisted of 15 sex- and age-matched kidney donors. The statistical adequacy of the sample size was preliminarily verified. Renal clearances were repeated after two years.
RESULTS: At baseline, GFR (mL/min/1.73 m2) averaged 81.4 +/- 3.8 in CAD and 83.7 +/- 1.4 in C (P= NS); RPF (mL/min/1.73 m2) was 297 +/- 22 in CAD and 456 +/- 15 in C (P < 0.0001); filtration fraction was higher in CAD (P < 0.001). Plasma renin activity was higher in CAD (P < 0.005). The number of coronary stenoses was inversely correlated with RPF but not with GFR. In CAD, at variance with C, AA did not induce any increment of GFR, while RPF increased without achieving the unstimulated value of C. Blood pressure was comparable in CAD and C at baseline and not modified by AA. After two years, a significant decrease in GFR (-14%, P < 0.001) and RPF (-15%, P < 0.001) occurred only in CAD, and in either group, the response to AA did not differ from that detected at baseline.
CONCLUSION: In CAD patients with normal GFR, reduction in renal perfusion and absence of renal functional reserve likely represent early markers of progressive renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316352     DOI: 10.1111/j.1523-1755.2005.00748.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

Review 1.  Atherosclerotic-nephropathy: an updated narrative review.

Authors:  Mariadelina Simeoni; Silvio Borrelli; Carlo Garofalo; Giorgio Fuiano; Ciro Esposito; Alessandro Comi; Michele Provenzano
Journal:  J Nephrol       Date:  2020-04-08       Impact factor: 3.902

Review 2.  Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors.

Authors:  Michele Andreucci; Teresa Faga; Antonio Pisani; Massimo Sabbatini; Domenico Russo; Ashour Michael
Journal:  ScientificWorldJournal       Date:  2014-11-30

3.  Kidney Injury Molecule 1 (KIM-1) as an Early Predictor for Acute Kidney Injury in Post-Cardiopulmonary Bypass (CPB) in Open Heart Surgery Patients.

Authors:  Nora A Khreba; Mostafa Abdelsalam; A M Wahab; Mohammed Sanad; Rania Elhelaly; Mohammed Adel; Ghada El-Kannishy
Journal:  Int J Nephrol       Date:  2019-03-12

4.  Smoking habit as a risk amplifier in chronic kidney disease patients.

Authors:  Michele Provenzano; Raffaele Serra; Ashour Michael; Davide Bolignano; Giuseppe Coppolino; Nicola Ielapi; Giuseppe Filiberto Serraino; Pasquale Mastroroberto; Francesco Locatelli; Luca De Nicola; Michele Andreucci
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

Review 5.  Acute kidney injury by radiographic contrast media: pathogenesis and prevention.

Authors:  Michele Andreucci; Teresa Faga; Antonio Pisani; Massimo Sabbatini; Ashour Michael
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

Review 6.  The potential use of biomarkers in predicting contrast-induced acute kidney injury.

Authors:  Michele Andreucci; Teresa Faga; Eleonora Riccio; Massimo Sabbatini; Antonio Pisani; Ashour Michael
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-09-09

Review 7.  Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate.

Authors:  Ahmed Alaini; Deepak Malhotra; Helbert Rondon-Berrios; Christos P Argyropoulos; Zeid J Khitan; Dominic S C Raj; Mark Rohrscheib; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Methodol       Date:  2017-09-26

8.  Haemodynamic or metabolic stimulation tests to reveal the renal functional response: requiem or revival?

Authors:  Bart De Moor; Johan F Vanwalleghem; Quirine Swennen; Koen J Stas; Björn K I Meijers
Journal:  Clin Kidney J       Date:  2018-04-13

9.  Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile.

Authors:  Michele Provenzano; Laura Rivoli; Carlo Garofalo; Teresa Faga; Elena Pelagi; Maria Perticone; Raffaele Serra; Ashour Michael; Nicolino Comi; Michele Andreucci
Journal:  PLoS One       Date:  2020-04-01       Impact factor: 3.240

10.  The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials.

Authors:  Carlo Garofalo; Ivana Capuano; Luigi Pennino; Ilaria De Gregorio; Eleonora Riccio; Michele Provenzano; Felice Crocetto; Pasquale Buonanno; Savio Domenico Pandolfo; Michele Andreucci; Antonio Pisani
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.